HHV8 ORF50 Polyclonal Antibody, PE-Cy5.5 Conjugated
Product Specifications
Background
HHV8 has been found to be associated with three different diseases observed in AIDS patients; kaposi's sarcoma, primary effusion lymphoma (which is a rare type of non-Hodgkin lymphoma affecting the body cavities) and multicentric Castleman's disease. To date there is much evidence to support a direct role for HHV8 in kaposi's sarcoma.
Synonyms
HHV 8; Human Herpes Virus 8; Human herpesvirus 8; HHV8 ORF50; Kaposi's sarcoma associated herpes virus; Kaposi's sarcoma associated herpesvirus; KSHV; replication and transcription activator; RTA
Gene ID
4961526
Swiss Prot
F5HCV3
Host
Rabbit
Cross Reactivity
Virus
Immunogen
2-100/691
Target
HHV8 ORF50
Clonality
Polyclonal
Isotype
IgG
Conjugation
PE-Cy5.5
Source
KLH conjugated synthetic peptide derived from N-terminus of HHV8 ORF50 strain GK18
Applications
WB
Purification
Purified by Protein A.
Excitation Emission
488nm/694nm
Concentration
1µg/µl
Dilution
WB (1:500-1000)
Buffer
Aqueous buffered solution containing 0.01M TBS (pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
Modification
Unmodified
Storage Conditions
Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
Gene ID URL
4961526
Cross Reactivity Details
Human herpesvirus 8, Kaposi's sarcoma-associated herpesvirus
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS6378901-01 0.1 mL
FPGT (Fucose-1-phosphate Guanylyltransferase, GDP-L-fucose Diphosphorylase, GDP-L-fucose Pyrophosphorylase, GFPP) APC
Sign In for Pricing
View Details MBS6378901-02 5x 0.1 mL
FPGT (Fucose-1-phosphate Guanylyltransferase, GDP-L-fucose Diphosphorylase, GDP-L-fucose Pyrophosphorylase, GFPP) APC
Sign In for Pricing
View Details